The combined use of known antiviral reverse transcriptase inhibitors AZT and DDI induce anticancer effects at low concentrations.
about
LINE-1 induces hTERT and ensures telomere maintenance in tumour cell lines.Regulatory roles of LINE-1-encoded reverse transcriptase in cancer onset and progression.Enhanced expression of LINE-1-encoded ORF2 protein in early stages of colon and prostate transformationCancer subclonal genetic architecture as a key to personalized medicine.Effects of azidothymidine on protein kinase C activity and expression in erythroleukemic cell K562 and acute lymphoblastic leukemia cell HSB-2.Telomere Transcripts Target Telomerase in Human Cancer Cells.Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration
P2860
Q34468156-D0F79CE4-CDD6-4BB8-8524-0E91C186EEB3Q34483462-690F6C5E-5C2C-4075-93AF-15023FE5785AQ36782347-78EF6B82-8FB8-46AE-A8CF-2BD9C995B07AQ37448116-6C27D2ED-291B-4FAB-AB8E-1F94B86E72B0Q38908302-C22FB59A-706D-4624-8E10-0F556C12FF64Q40571128-317E01D1-0EA4-4106-918C-ABECC1E8BD96Q41879186-D777BA43-F839-44FE-9994-4F9E0688EBA9
P2860
The combined use of known antiviral reverse transcriptase inhibitors AZT and DDI induce anticancer effects at low concentrations.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The combined use of known anti ...... effects at low concentrations.
@en
The combined use of known anti ...... effects at low concentrations.
@nl
type
label
The combined use of known anti ...... effects at low concentrations.
@en
The combined use of known anti ...... effects at low concentrations.
@nl
prefLabel
The combined use of known anti ...... effects at low concentrations.
@en
The combined use of known anti ...... effects at low concentrations.
@nl
P2093
P2860
P50
P356
P1433
P1476
The combined use of known anti ...... effects at low concentrations
@en
P2093
David Bernhard
Lisa Käser
Sandra Sampl
Thomas Aschacher
P2860
P356
10.1593/NEO.11426
P577
2012-01-01T00:00:00Z